Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Amiti Sen
GLENMARK Pharmaceuticals has scored in its patent tussle with Sanofi Aventis and Abbott after a New Jersey district court upheld the challenge by the Indian company for a hyper-tension drug.
In 2007, a paper in the journal Cancer Cell announced that the compound dichloroacetate (DCA) had been found to shrink tumours in rats (S. Bonnet et al. Cancer Cell 11, 37
Investors Put Off By 2016 Launch Date Given To Glenmark, Stock Sheds 1.7% GLENMARK Pharmaceuticals and US drugmaker Merck & Co have settled out of court their patent dispute over cholesterol control drug ezetimibe but investors were unimpressed with the terms of the deal, sending the company
Our Bureau NEW DELHI SWISS drugmaker Roche lost the patent in India for its anti-viral drug, Valcyte, widely used by AIDS patients, after the patent office concluded it did not contain the necessary innovation to qualify for marketing exclusivity, said lawyers involved in the case.
Driven by efforts to curb fossil-fuel use and concerns about the security of energy supplies, the number of applications for renewable-energy patents is booming. But the patents are scattered across many databases, in different formats that are not readily searchable, leading to a lack of clarity over who owns specific energy-technology patents, and in which regions.
THE European Commission has said the proposed free trade agreement (FTA) negotiations with India will not affect production of cheap life-saving medicines in the country.
Prior to the Copenhagen meeting on developing a new framework for climate-change policy there were sharp differences between the positions of developed and developing countries regarding the role of intellectual property rights (IPRs) in fostering international technology transfer (ITT). Expanding effective